Concordia Healthcare Corp (TSE:CXR) had its price target raised by equities researchers at TD Securities from C$7.00 to C$14.00 in a report released on Monday. The firm currently has a “hold” rating on the stock. TD Securities’ target price would indicate a potential upside of 106.49% from the company’s current price.

Other analysts have also recently issued research reports about the stock. Royal Bank Of Canada reissued an “outperform” rating and set a C$73.00 price target on shares of Concordia Healthcare Corp in a research report on Thursday, May 26th. Goldman Sachs Group Inc. assumed coverage on shares of Concordia Healthcare Corp in a research report on Tuesday, June 7th. They set a “neutral” rating and a C$42.00 price target on the stock. Finally, CIBC cut shares of Concordia Healthcare Corp from a “sector perform” rating to an “underperform” rating in a research report on Monday, August 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. Concordia Healthcare Corp presently has a consensus rating of “Hold” and a consensus target price of C$27.25.

Concordia Healthcare Corp (TSE:CXR) opened at 6.78 on Monday. Concordia Healthcare Corp has a 52-week low of $6.33 and a 52-week high of $92.11. The company’s market cap is $345.90 million. The firm’s 50-day moving average is $12.88 and its 200 day moving average is $28.09.

Receive News & Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.